Digestive Disease Week
(DDW 2023)
MAY 6-9, 2023 - CHICAGO, IL
DDW Encore: Non-invasive fibrosis scores as predictors for clinical events in obesity: a longitudinal study
This presentation outlines a longitudinal cohort study which investigated the prognostic potential of six non-invasive scores for NASH-related clinical outcomes in patients with obesity.
Understanding NASH as a metabolic disease
Read more on NASH as a metabolic disease, guideline recommendations, and Novo Nordisk's commitment to liver health
2021 AGA Clinical Care Pathway
Review the 2021 AGA Clinical Care Pathway for risk stratification-based disease management strategies.
Search the Exchange
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.
Find more information
Find product information
Survey Novo Nordisk’s portfolio of products and resources for the treatment of diabetes, obesity, liver health, and cardiovascular disease and treatments for rare bleeding, rare endocrine, and rare renal disorders.
Continuing education
Learn about accredited CE activities developed by third-party providers and supported by Novo Nordisk via independent medical education grants.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
